Ecolab Inc.
NYSE•ECL
CEO: Mr. Christophe Beck
セクター: Basic Materials
業種: Chemicals - Specialty
上場日: 1957-01-01
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through three segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. Its Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. In addition, the company provides pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments including education, life sciences, and healthcare customers. Further, it offers colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
連絡先情報
時価総額
$84.85B
PER (TTM)
40.7
20.1
配当利回り
0.9%
52週高値
$306.52
52週安値
$221.62
52週レンジ
順位22Top 8.4%
5.9
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5.9 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q4 2025 データ
売上高
$4.20B+0.00%
直近4四半期の推移
EPS
$2.00+0.00%
直近4四半期の推移
フリーCF
$0.00+0.00%
直近4四半期の推移
2025 Q3 決算ハイライト
主なハイライト
Organic Sales Growth Strong Reported GAAP net sales reached $4.17B, increasing 4%; organic sales grew 3% driven by pricing power.
Operating Income Rebounds Organic operating income increased 10% in Q3, despite GAAP operating income falling 27% due to prior year gain.
Adjusted EPS Rises Adjusted diluted EPS was $2.07, marking a 13% increase over Q3 2024 results, reflecting operational leverage.
Strong Cash Flow Generation Cash provided by operating activities totaled $1.86B for nine months, funding $716.2M in capital expenditures.
リスク要因
GAAP Net Income Drops Net income attributable to Ecolab decreased 21% to $585.0M in Q3, while diluted EPS fell 21% to $2.05.
Prior Year Gain Skews GAAP operating income dropped 27% due to comparison against Q3 2024 results impacted by large surgical business sale gain.
Global Economic Headwinds International operations face challenging macroeconomic environment, evolving trade policies, and geopolitical uncertainty risks.
Restructuring Liability Remains Restructuring liability for One Ecolab initiative stands at $64.8M, expected to be paid over several quarters.
見通し
One Ecolab Expansion Continues Anticipating $240M restructuring costs by 2027 for One Ecolab initiative, targeting $225M in annualized savings.
Major Acquisition Pending Entered agreement to acquire Ovivo Electronics for CAD 2.4B ($1.8B USD), subject to regulatory clearances.
Debt Refinancing Completed Issued $1.0B in new long-term debt during nine months 2025, supporting general corporate purposes.
Liquidity Position Strong Credit facility maturity extended to March 2030; expecting strong operating cash flow to fund foreseeable requirements.
同業比較
売上高 (TTM)
BHP$106.92B
VALE$36.93B
$34.59B
粗利益率 (最新四半期)
BHP126.1%
SCCO62.0%
AEM56.6%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| BHP | $186.32B | 20.4 | 19.7% | 22.5% |
| SCCO | $163.56B | 38.3 | 42.2% | 34.3% |
| NEM | $137.28B | 19.2 | 22.7% | 10.3% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
4.3%
緩やかな成長
4四半期純利益CAGR
11.9%
収益性の着実な向上
キャッシュフロー安定性
75%
キャッシュフローの変動が大きい
深度リサーチ
次回決算:2026年4月27日
EPS:-
|売上高:-
財務レポート
財務データ
全年度
Form 10-Q - Q3 2025
会計期末: 2025年9月30日|提出日: 2025年10月30日|売上高: $4.17B+4.2%|EPS: $2.06-20.8%予想通りForm 10-Q - Q2 2025
会計期末: 2025年6月30日|提出日: 2025年8月7日|売上高: $4.03B+1.0%|EPS: $1.85+7.6%予想通りForm 10-Q - Q1 2025
会計期末: 2025年3月31日|提出日: 2025年5月8日|売上高: $3.70B-1.5%|EPS: $1.42-1.4%予想を下回るForm 10-K - FY 2024
会計期末: 2024年12月31日|提出日: 2025年2月21日|売上高: $15.74B+2.7%|EPS: $7.43+54.1%予想を上回るForm 10-Q - Q3 2024
会計期末: 2024年9月30日|提出日: 2024年10月31日|売上高: $4.00B+1.0%|EPS: $2.60+83.1%予想を上回るForm 10-Q - Q2 2024
会計期末: 2024年6月30日|提出日: 2024年8月2日|売上高: $3.99B+3.5%|EPS: $1.72+48.3%予想通りForm 10-Q - Q1 2024
会計期末: 2024年3月31日|提出日: 2024年5月2日|売上高: $3.75B+5.0%|EPS: $1.44+75.6%予想を上回るForm 10-K - FY 2023
会計期末: 2023年12月31日|提出日: 2024年2月23日|売上高: $15.32B+8.0%|EPS: $4.82+25.8%予想を下回る